Adma Biologics: 3Q Earnings Snapshot

November 8, 2018

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $15.1 million in its third quarter.

On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 33 cents.

The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 33 cents per share.

The infectious disease drug developer posted revenue of $4.2 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $5.4 million.

Adma Biologics shares have climbed 79 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.74, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

Update hourly